Information: This is an outdated version of the data model. You can find a Versions overview via Versions on the left. You can find the newest Version by clicking here.
Information:
Error:
ID
11870
Description
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01) https://clinicaltrials.gov/ct2/show/NCT02419378 Principal Investigator Prof. Dr. Dr. Sven Meuth, University Hospital Muenster, Germany
Link
https://clinicaltrials.gov/ct2/show/NCT02419378
Keywords
Versions (3)
- 8/13/15 8/13/15 - Martin Dugas
- 5/24/16 5/24/16 -
- 5/28/16 5/28/16 -
Uploaded on
August 13, 2015
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0 Legacy
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
End of Study Multiple Sclerosis ALAIN01 NCT02419378
End of Study Multiple Sclerosis ALAIN01 NCT02419378
- StudyEvent: SE
Similar models
End of Study Multiple Sclerosis ALAIN01 NCT02419378
- StudyEvent: SE
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Patient ID (derived)
Item
Patient ID (derived)
text
C2348585 (UMLS CUI [1])
End of Study date
Item
Date of End of Study/Discontinuation
date
C2983670 (UMLS CUI [1])
CL Item
T (1)
CL Item
TM (2)
CL Item
M (3)
CL Item
Regular end of study (1)
CL Item
Early discontinuation (2)
CL Item
Patient s request (1)
CL Item
Medical, cognitive, or other conditions... (1)
CL Item
Screening failure (1)
CL Item
Other reason (9)
Discontinuation Reason
Item
End of Study: Reason for Discontinuation Text
text
C0457454 (UMLS CUI [1,1])
C0566251 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,2])
End of Study: Date of Signature
Item
date
CL Item
T (1)
CL Item
TM (2)
CL Item
M (3)
CL Item
yes (1)
CL Item
no (0)
Comment End of Study
Item
text